MedTrace Logo

Ketamine for Analgesia After Cesarean Section

NCT04545801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-09-16

No results posted yet for this study

Summary

In this prospective randomized trial, investigators compared the analgesic effect of subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section under spinal anesthesia.

Conditions

  • Cesarean Section
  • Postoperative Pain

Interventions

DRUG

0.25 mg/kg of Ketamine

patients will recieve 0.25mg/kg of ketamine intravenously 5 min after spinal anesthesia

DRUG

20ml of normal saline solution

20ml of normal saline solution intravenously 5 minutes after spinal anesthesia

Sponsors & Collaborators

  • Mongi Slim Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-03-31
Completion
2019-04-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04545801 on ClinicalTrials.gov